Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders

References

• Weinfeld A, Branehög J, Kutti J. Platelets in the myeloproliferative syndrome. Clin Haematol 1975; 4: 373–92
   PubMedGoogle Scholar
• Zucker S, Meilke C. Classification of thrombocytosis based on platelet function tests: correlation with haemorrhagic and thrombotic complication. J Lab Clin Med 1972; 80: 385–94
   PubMedGoogle Scholar
• Phadke K, Dean S, Pitney W R. Platelet dysfunction in myeloproliferative syndromes,. Am J Haematol 1981; 10: 57–64
   PubMed Web of Science ®Google Scholar
• Boneu B, Nouvel C, Sie P, Carenobe C, Combes D, Laurent G, Pris J, Bierne R. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests. Scand J Haematol 1980; 25: 214–20
   PubMedGoogle Scholar
• Boughton B J, Allington M, King A. Platelet and betathromboglobulin in myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 1978; 40: 125–32
   PubMed Web of Science ®Google Scholar
• Cortelazzo S, Viero P, Barbui T. Platelet activation in myeloproliferative disorders. Thromb Haemost 1981; 45(3)211–13
   Google Scholar
• Harker L H, Finch C A. Thrombokinetics in man. J Clin Invest 1969; 48: 963–74
   PubMed Web of Science ®Google Scholar
• Kotilainen M. Platelet kinetics in normal subjects and in haemotological disorders with special reference to the role of the spleen. Scand J Haematol 1969, Suppl. 5: 45–68
   Google Scholar
• Brodsky J, Kahn S B, Ross E M, Petkov G. Platelet and fibrinogen kinetics in the chronic myeloproliferation disorders. Cancer 1972; 30: 1440–50
   Google Scholar
• Brodsky J, Ross E M, Petkov G, Kahn S B. Platelet and fibrinogen kinetics with (75Se)-selenomethionine in patients with myeloproliferative disorders. Br J Haematol 1972; 22: 179–92
   Google Scholar
• Kutti J, Ridell B, Weinfeld A, Westin J. The relation of thrombokinetics to bone marrow megacaryocytes and to the size of the spleen in polycythemia vera. Scan J Haematol 1973; 10: 88–95
   PubMedGoogle Scholar
• Cunietti E, Gandini R, Mascaro G, Ferrari M, Pappalepore V, Scapallato L. Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative disorders. Scand J Haematol 1981; 26: 339–44
   Google Scholar
• Branehög J, Ridell B, Swolin B, Weinfeld A. The relation of platelet kinetics to bone marrow megacaryocytes in chronic granulocytic leukaemia. Scand J Haematol 1982; 29: 411–20
   Google Scholar
• du Heyns A P, Lötter M G, Badenhorst P N, van Reenen O R, Pieters H, Minnaar P C, Retief F P. Kinetics, distribution and sites of destruction of 111Indium-labelled human platelets. Br J Haematol 1980; 44: 269–80
   Google Scholar
• Badenhorst P N, Lötter M G, du Heyns A P, van Reenen O R, Herbst C, Pieters H, Kotze H F, Duyvené de Wit L J, Minnaar P C. The influence of the ‘collection injury’ on the survival and distribution of Indium-III-labelled canine platelets. Br J Haematol 1982; 52: 233–40
   Google Scholar
• Chesterman C N, McGready J R, Doyle D J, Morgen F J. Plasma levels of platelet factor 4 measured by radioimmunoassay. Br J Haematol 1978; 40: 489–500
   Google Scholar
• O'Brien J R, Etherington M C, Shuttlerworth R. Betathromboglobulin and heparin-neutralizing activity test in clinical conditions. Lancet 1977; 1: 1153
   Google Scholar
• O'Brien J R. ‘Exhausted’ platelets continue to circulate. Lancet 1978; 11: 1316–7
   Google Scholar
• Murphy S, Davis J L, Walsh P N, Gardner F H. Template bleeding time and clinical haemorrhage in myeloproliferative disease. Arch Intern Med 1978; 138: 1251–3
   PubMed Web of Science ®Google Scholar
• Pettit J E, Lewis S M, Nicholas A W. Transitional myeloproliferative disorder. Br J Haematol 1979; 43: 167–84
   Google Scholar
• Thakur M L, Welch M J, Joist J H. Indium-III-labelled platelet: studies on preparation and evaluation of in vitro and in vivo function. Thromb Res 1976; 9: 345–57
   PubMed Web of Science ®Google Scholar
• ICSH Panel on diagnostic application of radioisotopes in haematology. Recommended methods for radioisotope platelet survival studies. Blood 1977; 50: 1137–44
   Google Scholar
• Badson S R, Badson A L. Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations. Am J Clin Pathol 1978; 70: 406–8
   Google Scholar
• Gjerløff-Schmidt K, Rasmussen J W, Rasmussen A D, Arendrup H. Comparative studies of the in vivo kinetics of simultaneously infected 111In- and 51Cr-labelled human platelets. Scand J Haematol 1983; 30: 465–78
   Google Scholar
• Zahavi J, Kakker V V. β-thromboglobulin—a specific marker of in vivo platelet release reaction. Thromb Haemost 1980; 44: 23–9
   PubMed Web of Science ®Google Scholar
• Doyle D J, Chesterman C N, Cade J F, McGready J R, Rennie G C, Morgan F J. Plasma concentration of platelet specific proteins correlated with platelet survival. Blood 1980; 55: 82–4
   PubMed Web of Science ®Google Scholar
• Maldonado J E, Pintado T, Pierre R V. Dysplastic platelet and circulating megacaryocytes in chronic myeloproliferative disease. The platelets: Ultra-structure and peroxidasereaction. Blood 1974; 43: 797–809
   Google Scholar
• Harker L A, Slichter S J. Platelet and fibrinogen consumption in man. N Engl J Med 1972; 287: 999–1005
   PubMed Web of Science ®Google Scholar
• Eche N, Sie P, Caranobe C, Nouvel C, Pris J, Boneu B. Platelets in myeloproliferative disorders. III. Glycoprotein profile in relation to platelet function and platelet density. Scand J Haematol 1981; 26: 123–9
   PubMedGoogle Scholar
• Rendu F, Lebret M, Nurden A, Caen J P. Detection of an acquired platelet storage pool disease in three patients with a myeloproliferative disorder. Thromb Haemost 1979; 42: 794–5
   PubMed Web of Science ®Google Scholar
• Gerrard J M, Stoddard S F, Shapiro R S, Coccia P F, Ramsay N KC, Nesbit M E, Rao G HR, Krivit W, White J G. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukemia. Br J Haematol 1978; 40: 597–607
   PubMed Web of Science ®Google Scholar